Cancer

Cover image for Vol. 122 Issue 11

Edited By: Fadlo R. Khuri, MD

Impact Factor: 5.068

ISI Journal Citation Reports © Ranking: 2014: 32/211 (Oncology)

Online ISSN: 1097-0142

Associated Title(s): Cancer Cytopathology, CA: A Cancer Journal for Clinicians

Highlighted Papers

  • Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis

    Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis

    Liver tissue from rats receiving phosphate-buffered saline, Metformin, and/or diethylnitrosamine.

  • Irradiation and immunotherapy: From concept to the clinic

    Irradiation and immunotherapy: From concept to the clinic

    A) Signalling pathways involved in immunomodulatory responses. B) The immunomodulatory effects of radiation therapy.

  • Ototoxicity and cancer therapy

    Ototoxicity and cancer therapy

    Ototoxicity related to cancer therapy may affect the structures of the external or middle ear or the inner ear/cochlea.

  • Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma

    Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma

    Endoscopic retrograde cholangiopancreatography of unresectable perihilar cholangiocarcinoma before and after bilateral deployment of biliary stents.

  • Therapeutic radiation and the potential risk of second malignancies

    Therapeutic radiation and the potential risk of second malignancies

    Radiation fields and potential sites of subsequent second malignancies resulting from that treatment.

  • Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program

    Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program

    Clinical presentation of select dermatologic adverse events from cytotoxic or molecularly targeted agents.

  • Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance

    Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance

    Ablative proton and intensity-modulated radiotherapy (IMRT) plans for large liver tumors.

  • In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type

    In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type

    Photomicrographs of morphologic variants of adenoid cystic carcinoma.

  • Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis
  • Irradiation and immunotherapy: From concept to the clinic
  • Ototoxicity and cancer therapy
  • Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma
  • Therapeutic radiation and the potential risk of second malignancies
  • Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program
  • Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance
  • In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type

Recently Published Issues

See all

CancerScope

Cancer diagnosis

CancerScope

CancerScope

A Common Goal

Institutions consolidate vast amounts of data to produce innovative research and patient-centered care while minding funding limitations.

Click here to read this article
Click here to download the PDF




Stay up-to-date with
Cancer
Like Cancer on FacebookFollow Cancer on TwitterFollow Cancer Cytopathology on Google

SEARCH

SEARCH BY CITATION